Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
goeasy Ltd. Closes US$150 Million Offering of Senior Unsecured Notes

2018-07-16 globenewswire
MISSISSAUGA, Ontario, July 16, 2018 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY) (“goeasy” or the “Company”) is pleased to announce that it closed its offering of US$150 million 7.875% senior unsecured notes due November 1, 2022. These notes were issued at a price of US$1,050 per US$1,000 principal amount. Concurrently with the offering, goeasy entered into a cross currency swap agreement (the “Currency Swap”) to fix the foreign currency exchange rate for the proceeds from the offering and for all required payments of principal and interest under these notes.
GSY

0
goeasy Ltd. Refiles its 2017 and Q1 2018 Financial Statements and MD&A to Reclassify Certain Items in its Cash Flow Statements

2018-06-29 globenewswire
MISSISSAUGA, Ontario, June 29, 2018 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services that provides everyday Canadians with a chance for a better tomorrow, today refiled its financial statements and management’s discussion and analysis (“MD&A”) for the year ended December 31, 2017 and the three-month period ended March 31, 2018.
GSY

0
goeasy Ltd. Announces Increase to Credit Facility

2018-06-21 globenewswire
MISSISSAUGA, Ontario, June 21, 2018 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY) (“goeasy” or the “Company”) is pleased to announce that today it entered into an amendment to its pre-existing senior secured revolving credit facility (the “Credit Facility”) to increase the amount available to be borrowed thereunder and to adjust certain covenants.
GSY

0
goeasy Ltd. Announces Election of Directors

2018-05-03 globenewswire
MISSISSAUGA, Ontario, May 03, 2018 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services that provides everyday Canadians with a chance for a better tomorrow, today, announced that all of the nominee directors listed in the management proxy circular dated March 20, 2018 were elected as directors of goeasy.
GSY

0
goeasy Ltd. Reports Results for the First Quarter ended March 31, 2018

2018-05-01 globenewswire
MISSISSAUGA, Ontario, May 01, 2018 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services that provides everyday Canadians with a chance for a better tomorrow, today, announced its results for the first quarter ended March 31, 2018.
GSY

0
goeasy Ltd. Announces Timing of First Quarter 2018 Conference Call and Webcast

2018-04-18 globenewswire
MISSISSAUGA, Ontario, April 18, 2018 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY), (“goeasy” or the “Company”), a leading full-service provider of goods and alternative financial services that provides everyday Canadians with a chance for a better tomorrow, today, will hold a conference call with shareholders, analysts, and portfolio managers on Wednesday, May 2, 2018. A Press Release will be issued after the market closes on Tuesday, May 1, 2018.
GSY

28
goeasy: Their Competitors Are Leaving The Market

2018-04-14 seekingalpha
goeasy has a strong market runway as payday loan lenders are regulated out of the market.
WFC WFCNP WFC.WS GSY WFC.PRL WFC.PRJ WFC.PRT EHMEF WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV

0
goeasy Ltd. announces Senior Leadership Succession to sustain its strong growth and superior performance

2018-04-02 globenewswire
MISSISSAUGA, Ontario, April 02, 2018 (GLOBE NEWSWIRE) -- goeasy Ltd. (TSX:GSY), (“goeasy” or the “Company”), today announced that its Board of Directors has unanimously approved the recommendation of President and CEO David Ingram to implement a senior leadership succession plan. Jason Mullins, Executive Vice President and Chief Operating Officer, will succeed Mr. Ingram as President and CEO in January 2019.
GSY

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to TSX:GSY / Easyhome Ltd. on message board site Silicon Investor.

Energis PLC (ENGSY) Diginet Systems Corp. ..DGSY.